BGENE-DMD is designed to treat Duchenne muscular dystrophy (DMD) via a one-time administration in a single AAV.

Ipsen, a global specialty care biopharmaceutical company, has made the following changes to its Executive Committee: ...

Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from ...

Sygnature Discovery has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure.

Crown Bioscience’s San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification.

Roquette, a provider of plant-based ingredients and pharmaceutical excipients, has launched POLYOX Extended Stability (ES) packaging.